CEDARS-SINAI MEDICAL CENTER
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis is a funding opportunity from CEDARS-SINAI MEDICAL CENTER, up to 404788, closing January 31, 2027.
Jan 31, 2027
(184d left)Overview
PROJECT SUMMARY / ABSTRACT CRISPR technology have massively expanded our ability to interrogate the genetic mechanisms of cancer and define therapeutic avenues. Techniques have evolved over the past five years for the generation of massive scale CRISPR genetic screens linked to single cell transcriptomics. However,…